Literature DB >> 14683501

Thomsen-friedenreich disaccharide immunogenicity.

Fernando J Irazoqui1, Gustavo A Nores.   

Abstract

Mucin-type O-glycans are upregulated and aberrantly glycosylated in many carcinomas. O-glycan Core 1 (Galbeta1-3GalNAcalpha-O-), also called Thomsen-Friedenreich disaccharide, is a cryptic structure overexpressed in cancer cells through modification of its glycosyltransferase profile. This molecule is a useful model for study of carbohydrate immunogenicity as well as a candidate for active specific immunotherapy of cancer patients. Several strategies are discussed for enhancing immune response to a particular region of carbohydrate: carbohydrate-protein conjugation, linkers, synthetic clustered sugars, chemical modifications, peptide/protein mimetics, and molecular rotation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14683501     DOI: 10.2174/1568009033481714

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  3 in total

1.  Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen.

Authors:  Jamie Heimburg-Molinaro; Adel Almogren; Susan Morey; Olga V Glinskii; Rene Roy; Gregory E Wilding; Richard P Cheng; Vladislav V Glinsky; Kate Rittenhouse-Olson
Journal:  Neoplasia       Date:  2009-08       Impact factor: 5.715

Review 2.  Glycosylation and its research progress in endometrial cancer.

Authors:  Congli Pu; Kai Xu; Yingchao Zhao
Journal:  Clin Transl Oncol       Date:  2022-06-25       Impact factor: 3.340

Review 3.  Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential.

Authors:  Oleg Kurtenkov
Journal:  Biomed Res Int       Date:  2020-03-23       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.